Global Real Time PCR Kit Market Overview:
Real-time PCR helps in simultaneous amplification and detection of nucleic acids by the help of polymerase chain reaction (PCR). qPCR is a versatile technique which supports various research applications. Real-time PCR delivers sensitivity, specificity, and a wide dynamic range for detecting target nucleic acids. It is becoming a powerful technology for research applications which is able to cover the spectrum of biology from basic research to translational medicine to applied biology. Additionally, it is highly adopted by the pharmacological treatment, ventilators act as a vital treatment preference for COVID-19 patients. Furthermore, there is a growing requirement for a rapid production of wide range of test-kits includes antibody tests, self-administered, and others. In this COVID-19 situation the manufacturers such as Empirical bioscience revealed the enhancement of their production capacity to 50,000 kits a week to 100,000 a week. This kit helps in caters growing need for real-time COVID-19 testing. Major players revealed that they continue to accelerate their production and delivery time in the coming days. Some of the key players profiled in the study are Thermo Fisher Scientific (United States), Takara Bio Inc. (Japan), F. Hoffman-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (United States), Qiagen N.V. (Germany), Agilent Technologies, Inc. (United States), Fluidigm Corporation (United States), Danaher Corporation (United States), Abbott Laboratories (United States) and Merck KGaA (Germany).
On the basis of geography, the market of Real Time PCR Kit has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End Users, the sub-segment i.e. Hospitals will boost the Real Time PCR Kit market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Industry Verticals, the sub-segment i.e. Scientific Research will boost the Real Time PCR Kit market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing occurrence of Target Infectious Diseases and Genetic Disorders. Along with increasing Investments, Funds from governments and private players with the rising issue of COVID-19 across the globe. As it is highly adopted for the Biomarker Profiling for Disease Diagnostics. Simultaneously, an increasing the number of labs and diagnostic developers to meet the demand for detection of the SARS-CoV-2 coronavirus, across the US, European, and Asian markets.
- Technology Advancement to Detect Genetic Variations
- Expansion of Compact, Portable, And Lab-On-Chip PCR Devices
- Continuing Technological Integration with the PCR Process
- High Cost Associated with the Real-Time PCR Kit
- Continuous Change in The Technology
- Growing Market Penetration in Highest COVID-Affected Regions Such as China, The United States, Italy, And Others
- Rising Shift from Plant-Derived to Genome-Based Drug Discovery
- Lack of Supply Chain in Underdeveloped Regions
Major Market Developments:
In Apr 2020, Empirical Bioscience revealed their QuanTASE and QuanTASE PLUS One-Step RT-qPCR Kits under the testing protocol CDC. These kits help in identifying genetic material from the SARs-CoV-2 virus in one step. This kit converts the CoV-2 RNA to DNA and helps in detecting the presence of pathogenic material in patient samples.
In Feb 2020, QIAGEN announced the development of its shipment of QIAstat-Dx respiratory Panel COVID-19 to China. Through this initiative, the company is catering to the growing demand of automating higher-throughput processing of their laboratory-developed tests for COVID-19. Additionally, in Jan 2020, BGI revealed that they are developing a real-time fluorescent RT-PCR kit for the detection of the Novel Coronavirus. These kits are already issued to various hospitals and disease control centers.
The companies operating in this industry are focusing more on efficient growth, improvement of operational efficiency and productivity, achieving high safety standards, and focus on maintaining sustainable development. The players are focusing on securing the leading position in this industry. They are continuously looking for the opportunity to reinforce their competitive advantage. To meet a high market share, and developing socially responsible business companies are identifying various strategic pillars such as mergers & acquisitions, new product launch, product enhancement, and others.
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Real-Time PCR Kit Manufacturers, Suppliers and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries
Major Objectives Focused through this Study
To define, describe, and forecast the Global Real Time PCR Kit market on the basis of product [Type-it HRM PCR Kit (400) and Type-it HRM PCR Kit (2000)] , application [Gene expression (mRNA) analysis, Genetic variation analysis, MicroRNAs and noncoding RNA analysis, Virus Detection, Protein expression, Microbe detection, Fusion transcript detection, Duplexing and Others], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Real Time PCR Kit market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Real Time PCR Kit industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Becton Dickinson and Company (United States), Promega Corporation (United States) and Eppendorf AG (Germany).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Real Time PCR Kit market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.